Class II · Moderate risk Ongoing
Phentermine Hydrochloride Capsules
Reason cGMP deviations
Phentermine HCL Blue Speckled tablets
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.
What was recalled
Phentermine HCL Blue Speckled tablets, 37.5 mg, packaged in a) 14-count bags (NDC 10702-0025-10) and b) 28-count bags (NDC 10702-0025-10), Rx Only, Distributed by: Calvin Scott & Co., Inc. Albuquerque, NM 87123, MFG: KVK-Tech., Inc Newtown, PA 18940.
- Recalling firm
- Calvin Scott & Company, Inc.
- NDC code
- 10702-0025-10
- Origin
- NM, United States
- Initiated by
- Voluntary: Firm initiated
- FDA recall number
- D-1532-2020
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Other Phentermine recalls
See all
Class II · Moderate risk Terminated
Phentermine HCL 37.5mg 100 C4
Reason CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Class II · Moderate risk Terminated
Phentermine HCL 30mg 100 C4
Reason CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Class II · Moderate risk Terminated
Phentermine
Reason cMGP Deviations: Drug products repackaged into pouches without supporting stability studies.
Class II · Moderate risk Terminated
Phentermine HCL White/Blue Speckled tablets
Reason CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.
Get an alert if your medication is recalled
Tell us which medications you take. If the FDA recalls one, we email you - in plain English, with what to do. Free.